Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation
- PMID: 1695251
- PMCID: PMC249650
- DOI: 10.1128/JVI.64.8.3581-3589.1990
Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation
Abstract
We have constructed a series of mutants with deletion, linker insertion, and point mutations in the v-crk oncogene of avian sarcoma virus CT10. The v-crk gene contains no apparent catalytic domain, but does contain two blocks of homology to putative regulatory domains, termed SH2 and SH3, found in a variety of proteins implicated in signal transduction. Infection with CT10 causes a dramatic increase in the level of tyrosine phosphorylation of several cellular proteins. We found that mutation of either the SH2 or SH3 domain of v-crk reduced or eliminated transforming activity, whereas mutation of regions outside the conserved domains had no effect. Deletion of amino-terminal gag sequences caused a partial loss of transforming activity and a change in subcellular distribution of the crk protein. In all cases, there was an absolute correlation between increased cellular phosphotyrosine and transformation.
Similar articles
-
A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.Mol Cell Biol. 1993 Dec;13(12):7295-302. doi: 10.1128/mcb.13.12.7295-7302.1993. Mol Cell Biol. 1993. PMID: 7504172 Free PMC article.
-
Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.Mol Cell Biol. 1993 Aug;13(8):4648-56. doi: 10.1128/mcb.13.8.4648-4656.1993. Mol Cell Biol. 1993. PMID: 7687742 Free PMC article.
-
Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.J Virol. 1992 Jan;66(1):115-21. doi: 10.1128/JVI.66.1.115-121.1992. J Virol. 1992. PMID: 1370084 Free PMC article.
-
Emerging components of the Crk oncogene product: the first identified adaptor protein.Cell Signal. 1996 Aug;8(5):335-40. doi: 10.1016/0898-6568(96)00067-8. Cell Signal. 1996. PMID: 8911681 Review.
-
Physiological signals and oncogenesis mediated through Crk family adapter proteins.J Cell Physiol. 1998 Dec;177(4):535-52. doi: 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.0.CO;2-E. J Cell Physiol. 1998. PMID: 10092207 Review.
Cited by
-
A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.Mol Cell Biol. 1993 Dec;13(12):7295-302. doi: 10.1128/mcb.13.12.7295-7302.1993. Mol Cell Biol. 1993. PMID: 7504172 Free PMC article.
-
The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway.Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15394-9. doi: 10.1073/pnas.95.26.15394. Proc Natl Acad Sci U S A. 1998. PMID: 9860979 Free PMC article.
-
A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.EMBO J. 1994 Aug 15;13(16):3748-56. doi: 10.1002/j.1460-2075.1994.tb06684.x. EMBO J. 1994. PMID: 8070403 Free PMC article.
-
The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.Mol Cell Biol. 1996 Jan;16(1):45-52. doi: 10.1128/MCB.16.1.45. Mol Cell Biol. 1996. PMID: 8524328 Free PMC article.
-
Wee1-regulated apoptosis mediated by the crk adaptor protein in Xenopus egg extracts.J Cell Biol. 2000 Dec 25;151(7):1391-400. doi: 10.1083/jcb.151.7.1391. J Cell Biol. 2000. PMID: 11134069 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources